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Abstract 
Mutations of the lamin A gene cause various premature aging syndromes, including 
Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner syndrome. In 
HGPS (but not atypical Werner syndrome), the cardiovascular system is severely 
affected, and extensive loss of vascular smooth muscle cells leads to myocardial 
infarction with premature death. The molecular mechanisms by which lamin A 
mutations can cause such different premature aging phenotypes as HPGS and atypical 
Werner syndrome are largely unknown. We performed an interactome analysis using 
mutant forms of lamin A involved in progeroid syndromes. We found that the mutant 
lamin A responsible for HGPS, known as progerin, could not interact with proteins 
related to the DNA damage response, including DNA-dependent protein kinase 
(DNA-PK), unlike wild-type lamin A or lamin A mutants causing atypical Werner 
syndrome. We also found that forced expression of progerin in vascular smooth muscle 
cells led to activation of DNA-PK and cellular growth arrest, while knockdown of 
DNA-PK attenuated progerin-induced growth arrest. Deletion of p53 also improved the 
inhibition of cell growth due to forced expression of progerin. These findings suggested 
that progerin affects the DNA damage response pathway and that dysregulation of this 
pathway may be responsible for the development of cardiovascular pathology in 
patients with HGPS. 
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Introduction 
Hutchinson-Gilford progeria syndrome (HGPS) is among the most severe of the 
premature aging disorders and patients with HGPS die of cardiovascular complications 
at an average age of only 13 years
1, 2
. While lifestyle-related atherosclerosis involves 
vascular endothelial cell dysfunction, endothelial cell function is normal in HGPS 
patients
1
. Instead, they show loss of vascular smooth muscle cells (VSMCs) from the 
arterial media, which causes maladaptive vascular remodeling and leads to myocardial 
infarction
1
. 
 Lamin A is a component of the nuclear lamina, which lies on the inner surface 
of the nucleus, and it is involved in regulating multiple cellular functions such as 
maintenance of nuclear integrity, organization of chromatin, DNA replication, and 
transcription
3, 4
. Lamin A is encoded by the LMNA gene and mutations of this gene 
cause several diseases that affect specific types of mesenchymal cells such as muscle, 
white adipose tissue, and bone
3, 4
. Other LMNA mutations cause premature aging 
syndromes. The majority of HGPS patients have the G608G mutation that affects 
splicing in exon 11 to generate a truncated form of lamin A protein called progerin
3, 4
. In 
contrast, a subset of patients with Werner syndrome, a much less severe form of 
progeria with a median lifespan of 54 years
5
, have missense mutations such as R133L 
and L140R
3, 4
. 
 Several studies using mouse models or cells derived from progeria patients 
have suggested that DNA damage response pathways may be involved in the 
pathophysiology of HGPS. In Zmpste24
-/-
 mice that have similar phenotypic features to 
HGPS, the downstream targets of p53 were up-regulated and p53 deletion partially 
reversed some of the markers of premature aging including a shortened lifespan
6
. 
Phosphorylated histone H2AX is a marker of the response to DNA double-strand breaks, 
and it was found to be increased in these mice as well as in fibroblasts from HGPS 
patients
6, 7
. Ataxia telangiectasia mutated (ATM) is a kinase that is rapidly and 
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specifically activated in response to DNA double-strand breaks, and it was found to be 
activated in Zmpste24
-/-
 mice as well as in Lmna G609G/G609G mice that produce 
progerin and display clinical features of HGPS
8
. Changes in the localization and 
expression of DNA-dependent protein kinase (DNA-PK), another DNA damage 
response kinase, have been reported in HGPS fibroblasts, although the role of DNA-PK 
in HGPS is not clear
9
. Studies using induced pluripotent stem cells obtained from HGPS 
patients have detected cell type-specific toxicity of progerin for VSMCs
9, 10
, reflecting 
the unique pattern of arteriosclerosis in HGPS. 
  While there has been an increase in our knowledge of these syndromes, 
important questions remain unanswered. For example, “why do mutations of the same 
gene lead to such different premature aging phenotypes as HGPS and atypical Werner 
syndrome?”, “what causes cell-specific toxicity of progerin for cells with a 
mesenchymal origin?”, and “how are DNA damage response pathways related to the 
etiology of HGPS?”. In the present study, we attempted to address these issues by 
performing comparative interactome analysis of mutant forms of lamin A involved in 
HGPS and atypical Werner syndrome. 
 
Results 
Interactome analysis of wild-type and mutant lamin A 
In order to understand how mutation of lamin A causes more severe premature aging 
than other mutations in HGPS, we transfected HEK293 cells with four types of 
flag-tagged lamin A as the bait and performed immunoprecipitation of cell lysates with 
an anti-flag antibody, after which binding proteins were subjected to LC-MS/MS 
analysis. The baits were flag-tagged wild-type lamin A, flag-tagged lamin A R133L (a 
mutant causing atypical Werner Syndrome), flag-tagged lamin A L140R (another mutant 
causing atypical Werner Syndrome), and flag-tagged progerin (Figure 1). We identified 
55 binding partners of wild-type lamin A, which included some proteins previously 
  5 
reported to interact with lamin A, validating the quality of the present experiments 
(Table 2). The three lamin A mutants retained the ability to interact with some of the 
proteins that bound to wild-type lamin A, but most were no longer recognized. L140R 
was unable to bind with 30 of the 55 proteins, while R133L lost the ability to bind to 32 
proteins and progerin could not bind to 43 proteins (Figure 2 and Table 3). We also 
found that the lamin A mutants could interact with a substantial number of proteins to 
which wild-type lamin A could not bind (Figure 2 and Table 3). According to 
interactome analysis, progerin showed the largest loss and smallest gain in the number 
of protein-protein interactions compared with wild-type lamin A. These results led us to 
hypothesize that the normal lamin A protein network is most severely affected in HGPS 
among the laminopathies associated with premature aging and that alterations of protein 
interactions may contribute to the characteristic phenotypic features of this disease. 
 Next, we performed gene ontology (GO) analyses in order to detect functional 
differences between progerin-associated proteins. Using the functional annotation tool 
DAVID, we searched for GO terms concentrated in the sets of proteins interacting with 
wild-type lamin A, R133L, L140R, or progerin. Because several GO terms with similar 
functions showed almost complete overlap, we manually categorized them into common 
biological terms (Table 1). We found seven terms that were significantly enriched in 
wild-type lamin A-bound proteins (Table 1). Interestingly, proteins that interacted with 
any lamin A mutant causing atypical Werner syndrome usually shared almost all of 
these terms, although the interacting molecules did not correspond exactly to wild-type 
lamin A (Table 1 and Table 3). It is noteworthy that progerin lacked two terms when 
compared with the other three proteins, which were “DNA damage response” and 
“muscle” (Table 1). These data suggest that progerin has lost a set of interaction partners 
with specific functions rather than losing the ability to bind to proteins randomly. 
 
Lack of progerin/DNA-PK interaction is associated with activation of DNA-PK 
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We assigned the three GO terms “DNA-dependent protein kinase (DNA-PK)–DNA 
ligase 4 complex”, “non-homologous end joining complex”, and “replication fork” to 
the category of DNA damage response (Table 1). DNA-PKcs is the catalytic subunit of 
DNA-PK, a nuclear DNA-dependent serine/threonine protein kinase.
11
 DNA-PKcs is 
required for the non-homologous end joining (NHEJ) DNA repair pathway, which 
repairs double-strand breaks in DNA. We focused on the term “DNA-dependent protein 
kinase–DNA ligase 4 complex” because DNA-PKcs and its binding partners Ku80 and 
Ku70 were all detected in the interactomes of wild-type lamin A, R133L, and L140R, 
while none of them were detected among the progerin-associated proteins (Table 3). 
 Many proteins have been identified as substrates for the kinase activity of 
DNA-PK. Autophosphorylation of DNA-PKcs appears to play a key role in NHEJ and 
is thought to induce a conformational change that allows end-processing enzymes to 
access the ends of the double-strand break. In addition, DNA-PKcs has been reported to 
interact with a number of regulators of DNA metabolism. To investigate the interaction 
between progerin and DNA-PKcs, we transfected cells with flag-tagged lamin A or 
flag-tagged progerin and then performed immunoprecipitation with an anti-flag 
antibody and western blot analysis for DNA-PKcs expression. DNA-PKcs was easily 
detected when cells were transfected with flag-tagged lamin A, while it was markedly 
reduced in cells transfected with flag-tagged progerin (Figure 3A), validating the results 
obtained by mass spectrometry. To examine how lamin A influenced the activation of 
DNA-PKcs, we further assessed its phosphorylation. While introduction of wild-type 
lamin A did not affect the phosphorylation of DNA-PKcs, introduction of progerin led 
to a marked increase of its phosphorylation (Figure 3B). These results suggested that 
accumulation of progerin could increase the activity of DNA-PK by changing its 
binding properties. 
 
Progerin impairs VSMC growth in a DNA-PK and p53-dependent manner 
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Because VSMCs rather than vascular endothelial cells are involved in arteriosclerosis 
associated with HGPS, we tested the influence of progerin on the growth of VSMCs and 
human umbilical vein endothelial cells (HUVECs) by using a retroviral vector that 
encoded wild-type lamin A or progerin. Introduction of progerin into VSMCs strongly 
reduced cell growth and shortened the replicative lifespan (Figure 4A and B). In contrast, 
introduction of progerin had no effect on the growth and lifespan of HUVECs (Figure 
4C and D), showing a cell type-specific effect of progerin. These results are consistent 
with the known pathology of HGPS as well as with a previous report about iPS cells
10
. 
 We next examined whether knockdown of DNA-PKcs with small interfering 
RNA (siRNA) could improve the growth of VSMCs after introduction of progerin. We 
found that siRNA targeting DNA-PKcs reduced the DNA-PKcs protein level in cultured 
VSMCs (Figure 5A). In addition, knockdown of DNA-PKcs reversed the suppression of 
cell growth by progerin (Figure 5B and C), suggesting that activation of DNA-PK could 
account for the antiproliferative effect of progerin on VSMCs. 
 VSMC numbers did not increase when culture was continued for 2 months 
after introduction of progerin. When we harvested these cells and performed western 
blot analysis of cell cycle checkpoint proteins related to the DNA damage response and 
cellular senescence, we found that expression of p53, p21, and p16 was increased by 
introduction of progerin compared with wild-type lamin A (Figure 6A). It is well known 
that DNA-PK cooperates with ATM, leading to phosphorylation and activation of p53
12, 
13
. Accordingly, we speculated that progerin-induced activation of DNA-PK might 
up-regulate p53 activity, thereby inducing cell growth arrest. To test this hypothesis, we 
introduced siRNA targeting p53 into progerin-infected VSMCs and found that this 
siRNA counteracted the anti-proliferative effect of progerin on VSMC growth (Figure 
6B and C). These results suggested that progerin suppresses VSMC growth via 
activation of the DNA damage response pathway. 
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Progerin upregulates pro-inflammatory gene expression in a NF-B-dependent, 
but DNA-PK-independent, manner 
Accumulation of prelamin A isoforms at the nuclear lamina was reported to trigger 
activation of NF-B and secretion of high levels of pro-inflammatory cytokines in two 
different mouse models of HGPS
8
. We investigated whether progerin overexpression in 
VSMCs upregulated pro-inflammatory molecules via a DNA-PK dependent pathway. 
Microarray analysis revealed upregulation of the production of pro-inflammatory 
cytokines and extracellular proteases (including MMP-3, GM-CSF, and IL-8) by 
VSMCs after introduction of progerin compared with wild-type lamin A (Table 4). 
Upregulation of these molecules was also confirmed by real-time PCR (Figure 7). 
Inhibition of NF-B signaling by siRNA targeting RELA (p65) attenuated the 
progerin-induced upregulation of GM-CSF and IL-8, while MMP-3 expression was not 
significantly affected (Figure 7). We next tested three siRNAs targeting DNA-PKcs or 
ATM, but none of them downregulated the expression of these pro-inflammatory 
molecules (Figure 7 and data not shown), suggesting that progerin-induced 
inflammatory gene activation is independent of DNA-PK activation. 
 
Discussion 
In the present study, we performed affinity purification using wild-type lamin A and 
three mutant forms of lamin A associated with premature aging syndromes as the bait, 
employing mass spectrometry for analysis of the samples. As a result, we identified over 
50 proteins that had not been previously recognized as binding to lamin A. We found 
that part of this protein network was shared between wild-type lamin A and the lamin A 
mutants that cause atypical Werner syndrome, although more than half of these proteins 
did not interact with the mutants. In addition, only a few of the proteins bound to 
progerin, suggesting that the mutation underlying HGPS most severely impairs the 
ability of lamin A to interact with functional proteins. Consistent with this concept, our 
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GO functional analysis revealed that progerin did not interact with a set of proteins that 
had functions categorized into “DNA damage response” and “muscle”, while the two 
lamin A mutants causing atypical Werner syndrome still interacted with proteins related 
to the “DNA damage response”. Since about 25% of lamin A-binding proteins fitted 
into this category, we focused on the DNA damage response. Among DNA-PKcs and its 
associated proteins, Ku80 and Ku70 were found to interact with wild-type lamin A and 
the two mutants causing atypical Werner syndrome, but not with progerin. We also 
demonstrated that overexpression of progerin upregulated DNA-PKcs phosphorylation 
in VSMCs and induced premature senescence of these cells, while DNA-PK 
knockdown reversed progerin-induced cell growth arrest. These results suggested that 
reduced binding of progerin to various proteins interferes with the DNA damage 
response, leading to the development of vascular pathology in HGPS. 
 While data from several mouse models of HGPS have suggested the 
importance of the DNA damage response,
6, 8, 9
 the actual role of this pathway remains 
unclear. Osorio et al. reported that accumulation of progerin triggers a signaling 
pathway involving ATM that activates NF-B,8 and they also demonstrated that 
NF-B-driven inflammation is responsible for several important features of the 
progeroid phenotypes. Interestingly, inhibition of the NF-B pathway by genetic or 
pharmacological strategies was able to prevent these phenotypic alterations, 
demonstrating the causal role of this inflammatory pathway in the pathogenesis of 
accelerated aging. In agreement with their results, we showed that introduction of 
progerin into VSMCs led to upregulation of pro-inflammatory genes, while inhibition of 
NF-B signaling attenuated the inflammatory response induced by progerin. However, 
inhibition of ATM or DNA-PK failed to inhibit progerin-induced upregulation of 
pro-inflammatory genes in VSMCs, suggesting progerin induces inflammation via a 
mechanism that is independent of the DNA damage response. 
 Signaling kinases (ATM, ATR and, DNA-PK) are recruited to sites of DNA 
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damage and are activated at these sites, leading to the local assembly of checkpoint and 
DNA repair factors and promoting the phosphorylation of transducer kinases (Chk1 and 
Chk2), which converge on p53
14
. Marked upregulation of p53 target genes has been 
reported in a mouse model of HGPS, while blocking the activation of p53 attenuates 
premature aging
6
. In aged HGPS cells, Liu et al. found an increase of phosphorylated 
Chk1 and Chk2 owing to the activation of ATM and ATR 
15
. Phosphorylated p53 was 
also increased, demonstrating that the ATR and ATM checkpoints were persistently 
activated, as also confirmed by other researchers
16-18
. In the present study, we 
demonstrated that accumulation of progerin leads to activation of DNA-PK and plays a 
causal role in senescence of VSMCs, providing evidence that DNA-PK could contribute 
to the pathogenesis of HGPS. 
 Various explanations have been proposed for the cell type-specific pathology of 
laminopathies, including progerin-mediated exhaustion of stem cell pools
19
, defects of 
mesenchymal lineage differentiation
20
, impairment of the DNA damage repair 
response
21
, and nuclear fragility in mechanically stressed cells such as cardiomyocytes
22
. 
Recently, Liu et al. generated induced pluripotent stem cells (iPSCs) from the 
fibroblasts of patients with HGPS. They elegantly demonstrated that progerin 
expression and associated premature senescence were markedly suppressed in the 
pluripotent state, while the aging phenotype emerged along with progerin expression 
after differentiation of the cells into VSMCs. However, this does not occur when 
HGPS-iPSCs undergo differentiation into fibroblasts
9
. Zhang et al. also generated 
HGPS-iPSCs and found that progerin levels were highest in mesenchymal stem cells 
(MSCs) and VSMCs differentiated from the pluripotent cells
10
. Because these cells were 
sensitive to various stresses, they speculated that progeria may be related to a shortage 
of MSCs needed for tissue repair. In the present study, we observed that forced 
expression of progerin induced premature senescence of VSMCs, but not endothelial 
cells, although the mechanisms underlying these observations are still obscure. 
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 In conclusion, our findings suggest that progerin inhibits VSMC growth via the 
DNA damage response pathway and that this pathway probably contributes to the 
pathogenesis of HGPS. Further interactome analysis of lamin A mutants involved in 
premature aging syndromes could provide a platform for future studies on the link 
between lamin A and premature aging. 
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Materials and Methods 
Cell culture 
HEK293 cells were cultured in DMEM (Sigma) supplemented with 10% FBS, 
streptomycin (0.1 μg ml–1), and penicillin G (100 units ml–1). Human VSMCs and 
HUVECs were purchased from Lonza and cultured according to the manufacturer’s 
instructions. Culture was done at 37oC in a humidified incubator with 5% CO2 and 
proliferation was assessed by counting cells after subculture. We defined senescent cells 
as those that did not increase in number and remained subconfluent after 2 weeks of 
culture. The number of population doublings (PD) was calculated as follows: PD=log 
(number of cells after culture/initial number of cells)/log 2. 
 
Transfection of expression vectors and retroviral infection 
The expression vector pcDNA
TM
5/FRT/TO (Invitrogen) was cut with Bam H I and Xho 
I. Fragments of lamin A , progerin, lamin A R133L, or lamin A L140R were ligated into 
the corresponding restriction sites of pcDNA
TM
5/FRT/TO. The resulting expression 
vectors were transfected into HEK293 cells by using Fugene. We created vectors based 
on pLNCX2 (Clontech, Palo Alto, CA, USA) that expressed wild-type lamin A or 
progerin for retroviral infection, which was done as described previously 
23
. Briefly, 
VSMCs or HUVECs (passages 4–6) were plated at 5×105 cells in 100-mm dishes at 24 
hours before infection. Then the culture medium was replaced by retroviral stock 
medium supplemented with 8 μg ml–1 polybrene (Sigma). From 48 hours after infection, 
the cells were selected by culture for 7 days in 500 μg ml–1 G418. After selection, 2×105 
cells were seeded in 100-mm dishes on the 8th day post-infection, which was 
designated as day 0. The respective empty vectors were used as controls. In some 
experiments, after retroviral infection had been performed, siRNAs purchased from 
Ambion or Invitrogen were transfected at 10 nmol l
-1
 with RNAiFect (Qiagen) or 
Lipofectamine RNAiMAX (Invitrogen) according to the instructions of the respective 
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manufacturers. 
 
Western blot analysis 
Whole-cell lysates were prepared in lysis buffer (10 mM Tris-HCl, pH 8, 140 mM NaCl, 
5 mM EDTA, 0.025% NaN3, 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 1 mM 
PMSF, 5 g ml–1 leupeptin, 2 g ml–1 aprotinin, 50 mM NaF, and 1 mM Na2VO3). The 
lysates (40–50 g) were resolved by SDS-PAGE and proteins were transferred to a 
PVDF membrane (Millipore), which was incubated with the primary antibody followed 
by anti-rabbit or anti-mouse immunoglobulin-G conjugated with horseradish peroxidase 
(Jackson). Specific proteins were detected by the enhanced chemiluminescence method 
(Amersham). The primary antibodies used for western blotting were as follows: 
anti-p53 antibody (#2524), anti-actin antibody (#4967) (Cell Signaling), and 
anti-GAPDH antibody (sc-20357, Santa Cruz), anti-DNA-PK cs antibody (sc-9051, 
Santa Cruz), anti-phospho-DNA-PK cs antibody (Thr2609) (sc-101664, Santa Cruz), 
anti-Rabbit Monoclonal Anti-FLAG antibody (F2555, Sigma). 
 
Real-time PCR 
Total RNA (1 g) was isolated from tissue samples with RNA-Bee (Tel-Test Inc.). 
Real-time PCR (qPCR) was performed by using a Light Cycler 480 (Roche) with the 
Taqman Universal Probe Library and the Light Cycler 480 Probes Master (Roche) 
according to the manufacturer’s instructions. For quantification of the copy number, we 
used Light Cycler 480 software (version 1.5, Roche) and employed the ‘fit points’ 
method according to the manufacturer’s instructions. GAPDH was used to normalize 
the amount of mRNA in each sample. 
 
Transcriptome analysis 
VSMCs with p53 deficiency (overexpressing E6) were infected with retroviral vectors 
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encoding lamin A or progerin and cells were harvested after 30 days. Then total RNA 
was isolated with RNA-Bee (Tel-Test, Inc.) and the genetic profile of lamin A and 
progerin were analyzed by using a Human Gene Expression 4x44K v2 Microarray Kit 
(Agilent Technologies) (n=4 per group). Raw data were subjected to log2 
transformation and normalized by using GeneSpring GX v7.3.1 (Agilent Technologies). 
Genes showing differential expression (q<0.05) were determined by BH-FDR. Gene 
ontology analysis was performed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) v6.7. Finally, the gene expression data thus obtained 
were deposited in the Gene Expression Omnibus database (GSE47553). 
 
Identification of proteins by LC-MS/MS 
Immunoprecipitated protein samples (approximately 100 μl) were mixed with 400 μl of 
methanol. 100 μl chloroform was mixed with the samples, followed by the addition of 
300 μl distilled water and stirred for 2 minutes. After centrifugation at 2,000 rpm for 2 
minutes, the supernatant was removed and 300 μl methanol was added. After 
centrifugation at 15,000 rpm for 5 minutes, the supernatant was removed and the 
samples were dried with an evaporator. Dried samples were dissolved with the buffer 
including 180 mg urea, 0.12 M Tris HCl buffer 1.5M Tris HCl (pH 8.8) 33.3 μl, and 
H2O 370 μl, then mixed with 2 μl Tris (2-CarboxyEthyl) Phosphine (TCEP), and 
incubated at 37 °C for 2 hours. One μl of methyl-methane-thio-sulphonate (MMTS) was 
added and incubated at room temperature for 10 minutes, followed by overnight 
incubation with 1 μl lysyl endopeptidase. Digested samples were dried with an 
evaporator, and then dissolved with 200 μl of 2% acetonitrile/0.1% trifluoroacetic acid. 
The samples were desalted with a tip made with C18 Empore Disk. The tips including 
samples were added with 100 μl of 70% acetonitrile/0.1% trifluoroacetic acid. Samples 
were centrifuged at 2,000 rpm for 5 minutes and the flow-through was discarded. 100 μl 
of 2% acetonitrile/0.1% trifluoroacetic acid was added and centrifuged at 2,000 rpm for 
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5 minutes. The flow-through was discarded followed by the addition of 200 μl of 2% 
acetonitrile/0.1% trifluoroacetic acid. Each 100 μl of samples was added to 2 tips, and 
was centrifuged at 2,000 rpm for 5 minutes, followed by the discard of the flow-through. 
The tip was loaded onto a new 1.5 ml tube, 100 μl of 2% acetonitrile/0.1% 
trifluoroacetic acid was added onto the tip, and the tubes were centrifuged.  Eluted 
samples were dried with an evaporator, and dissolved with 12 μl of 2% 
acetonitrile/0.1% formic acid, followed by centrifugation at 15,000 rpm for 5 minutes. 
The supernatant was used for LC-MS/MS analysis. The data were analyzed using 
MASCOT software (Matrix Science, Wyndham Place, UK). Biogrid 
(http://thebiogrid.org/) was used to analyze if identified proteins are novel or previously 
reported. The proteins thus identified were categorized with the Database for 
Annotation, Visualization and Integrated Discovery (DAVID v6.7). 
 
Statistical analysis 
Results are shown as the mean  SEM. The two-tailed Student’s t-test or one-way 
ANOVA was used to assess the statistical significance of differences. In all analyses, 
P<0.05 was considered significant.  
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Figure legends 
Figure 1 Isolation of lamin A or lamin A mutants-associated complexes. 
 
Wild-type lamin A or lamin A mutant-associated complexes were isolated by 
immunoprecipitation from HEK293 cells transfected with lamin A or lamin A mutant 
expression vectors (progerin, R133L, L140R). The immune-isolated complexes were 
resolved by SDS-PAGE on a 12.5% gel followed by silver staining. Untransfected HEK 
293 cells were used in control experiments (control). Asterisks indicate FLAG-tagged 
lamin A or lamin A mutants. 
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Figure 2 Venn diagram for the interactome analysis 
 
We identified 55 binding partners of wild-type lamin A, but most were not recognized 
by lamin A mutants, in particular, progerin. 
 
Figure 3 Progerin loses affinity with DNA-PK and activates it 
  
(A) An expression vector encoding flag-tagged wild-type lamin A or progerin was 
transduced into HEK293 cells, after which co-immunoprecipitation was conducted with 
anti-flag antibody. Then the samples were subjected to western blot analysis for 
detection of DNA-PKcs and flag protein. The empty vector was used as a control.  
(B) An expression vector encoding flag-tagged wild-type lamin A or progerin was 
transduced into HEK293 cells, following which the levels of phosphorylated 
DNA-PKcs and flag protein were examined by western blot analysis. 
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Figure 4 Progerin impairs the growth of VSMCs but not HUVECs 
 
  
(A) VSMCs were infected with a retroviral vector encoding wild-type lamin A or 
progerin and population doubling was examined. (B) Representative pictures of VSMCs 
infected with the wild-type lamin A vector or progerin vector. Scale bar=100 μm. (C) 
HUVECs were infected with a retroviral vector encoding wild-type lamin A or progerin 
and population doubling was examined. (D) Representative pictures of HUVECs 
infected with the wild-type lamin A vector or the progerin vector. Scale bar=100 μm. 
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Figure 5 DNA-PKcs knockdown attenuates progerin-induced inhibition of VSMC 
growth 
 
(A) VSMCs were infected with a retroviral vector encoding progerin with or without 
siRNA targeting DNA-PKcs, after which expression of DNA-PKcs was examined by 
western blot analysis. (B) Population doubling was examined using VSMCs prepared as 
explained in (A). (C) Representative pictures of VSMCs prepared as explained in (A). 
Scale bar=100 μm. 
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Figure 6 p53 knockdown ameliorates progerin-induced inhibition of VSMC growth  
  
(A) VSMCs were infected with a retroviral vector encoding wild-type lamin A or 
progerin, following which expression of p53, p21, and p16 was examined by western 
blot analysis. (B) VSMCs were infected with a retroviral vector encoding progerin with 
or without siRNA targeting p53, after which population doubling was examined. (C) 
Representative pictures of VSMCs prepared as explained in (B). Scale bar=100 μm. 
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Figure 7 Knockdown of RelA, but not DNA-PK, attenuates progerin-induced 
upregulation of pro-inflammatory molecules in VSMCs 
 
 
VSMCs were infected with a retroviral vector encoding wild-type lamin A or progerin 
and with siRNA targeting the NF-κB component RELA (p65) or DNA-PKcs. Then 
expression of MMP3, GM-CSF, and IL-8 was examined by real-time PCR. Control 
siRNA was also transfected as a control. NS, not significant. * P < 0.05. ** P < 0.01. 
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Table1：Gene Ontology terms of proteins ineteracted with wild-type lamin A, R133L, 
L140R, or progerin. 
 lamin A progerin R133L L140R 
DNAdamage 
response ●  ● ● 
Muscle ●    
Cytoskeleton ● ● ● ● 
Intranuclear ● ● ● ● 
nuclear lamina ● ● ● ● 
nuclear membrane ● ● ● ● 
nuclear periphery ● ● ● ● 
DNA Damage Response 
DNA-dependent protein kinase-DNA ligase 4 complex, nonhomologous end joining complex  
muscle 
contractile fiber, contractile fiber part, fascia adherens, I band, myofibril, sarcomere, Z disc 
cytoskeleton 
actin cytoskeleton, Arp2/3 protein complex, cortical actin cytoskeleton, cytoskeleton, cytoskeletal part, 
intermediate filament, intermediate filament cytoskeleton, lamin filament, spectrin 
intranuclear 
chromatin, chromosome, chromosomal part, chromosome telomeric region, DNA replication factor A 
complex, intracellular organelle lumen, nuclear chromosome, nuclear chromosome part, nuclear 
chromosome telomeric region, nuclear matrix (p, 133), nuclear replication fork, nuclear replisome, 
nuclear telomere cap complex, nucleoplasm, nucleoplasm part, replisome, telomere cap complex 
nuclear lamina 
lamin filament (p, 133,140), nuclear lamina  
nuclear membrane 
endomembrane system, membrane-enclosed lumen (133), nuclear inner membrane, nuclear membrane, 
organelle inner membrane (p,133), organelle membrane, protein-DNA complex 
nuclear periphery 
cell-cell adherens junction (140), cell cortex, cell leading edge, cell projection, envelope, intercalated 
disc, intracellular non-membrane-bounded organelle, intracellular organelle lumen, lamellipodium, 
membrane-enclosed lumen, non-membrane-bounded organelle, nuclear envelope, nuclear lumen, nuclear 
periphery, nuclear pore, organelle envelope, organelle lumen, pore complex,  
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Table2：Binding partners of wild-type lamin A 
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Table3：binding partners of wild-type and mutant lamin A 
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Table4：Microarray analysis 
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